How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput

Cryo-electron microscopy can deliver near-atomic and, in favorable cases, atomic-resolution protein structures, but sample preparation and grid optimization remain major bottlenecks. Immuto Scientific, co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D. and CTO Daniel Benjamin, Ph.D., both electrical engineers by training, is making a narrower pitch: that for selected workflows, especially antibody-antigen analysis, its… The post How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput appeared first on Drug Discovery and Development.

Continue reading →